611
Views
0
CrossRef citations to date
0
Altmetric
Licensed Vaccines

Economic burden of pertussis in children: A single-center analysis in Hangzhou, China

, , , , , , , , & ORCID Icon show all
Article: 2343199 | Received 15 Jan 2024, Accepted 11 Apr 2024, Published online: 22 Apr 2024

References

  • Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet. 2006;367(9526):1926–7. doi:10.1016/S0140-6736(06)68848-X.
  • WHO. Pertussis vaccines: WHO position paper, August 2015–Recommendations. Vaccine. 2016;34(12):1423–1425. doi:10.1016/j.vaccine.2015.10.136.
  • Fry NK, Campbell H, Amirthalingam G. JMM profile: Bordetella pertussis and whooping cough (pertussis): still a significant cause of infant morbidity and mortality, but vaccine-preventable. J Med Microbiol. 2021;70(10):001442. doi:10.1099/jmm.0.001442.
  • Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis. 2003;3(7):413–418. doi:10.1016/S1473-3099(03)00669-8.
  • Liu TC, Zhang J, Liu SQ, Yin AT, Ruan SM. Evaluation of immunisation strategies for pertussis vaccines in Jinan, China - An interrupted time-series study. Epidemiol Infect. 2020;148:e26. doi:10.1017/S0950268820000102.
  • Nguyen VTN, Simon L. Pertussis: The whooping cough. Prim Care. 2018;45(3):423–431. doi:10.1016/j.pop.2018.05.003.
  • Winter K, Zipprich J, Harriman K. Pertussis in California: a tale of 2 epidemics. Pediatr Infect Dis J. 2018;37(4):324–328. doi:10.1097/INF.0000000000001761.
  • State Health Commission for Disease Control and Prevention. Epidemic situation of notifiable infectious diseases in China in 2019. http://www.nhc.gov.cn/jkj/new_index.shtml.
  • Stojanov S, Liese J, Belohradsky BH. Hospitalization and complications in children under 2 years of age with Bordetella pertussis infection. Infection. 2000;28(2):106–110. doi:10.1007/s150100050056.
  • Riffelmann M, Littmann M, Hülsse C, O’Brien J, Wirsing von König CH. Pertussis: incidence, symptoms and costs. Dtsch Med Wochenschr. 2006;131(50):2829–2834. doi:10.1055/s-2006-957208.
  • Xu Y, Wang L, Xu J, Wang X, Wei C, Luo P, Ma X, Hou Q, Wang J. Seroprevalence of pertussis in China: need to improve vaccination strategies. Hum Vaccin Immunother. 2014;10(1):192–198. doi:10.4161/hv.26335.
  • Dorji D, Mooi F, Yantorno O, Deora R, Graham RM, Mukkur TK. Bordetella pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance. Med Microbiol Immunol. 2018;207(1):3–26. doi:10.1007/s00430-017-0524-z.
  • Yeung KHT, Duclos P, Nelson EAS, Hutubessy RCW. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis. 2017;17(9):974–980. doi:10.1016/S1473-3099(17)30390-0.
  • Wu D, Jing R, Zheng H, He K, Li Y, Yu W, Yin Z, Fang H. Health and economic evaluation of vaccination against pertussis in China: A 40-year analysis. Value Health. 2023;26(5):666–675. doi:10.1016/j.jval.2022.10.011.
  • WHO Publication. Pertussis vaccines: WHO position paper–recommendations. Vaccine. 2011;29(13):2355–2356. doi:10.1016/j.vaccine.2010.11.059.
  • Sánchez-González G, Luna-Casas G, MascareñMascareñAs C, Macina D, Vargas-Zambrano JC. Pertussis in Mexico from 2000 to 2019: a real-world study of incidence, vaccination coverage, and vaccine effectiveness. Vaccine. 2023;41(41):6105–6111. doi:10.1016/j.vaccine.2023.08.046.
  • Rohani P, Drake JM. The decline and resurgence of pertussis in the US. Epidemics. 2011;3(3–4):183–188. doi:10.1016/j.epidem.2011.10.001.
  • Domenech de Cellès M, Magpantay FM, King AA, Rohani P. The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc Biol Sci. 2016;283(1822):20152309. doi:10.1098/rspb.2015.2309.
  • Liu Z, Liu S, Shu Y, Yang Z, Peng B, Xu H, Li Q, Luo Z, Dai J, Liu E, et al. Severe Bordetella pertussis infection and vaccine issue in Chongqing, from 2012 to 2018. Int J Infect Dis. 2019;84:102–108. doi:10.1016/j.ijid.2019.05.014.
  • Skoff TH, Hadler S, Hariri S. The epidemiology of nationally reported pertussis in the United States, 2000-2016. Clin Infect Dis. 2019;68(10):1634–1640. doi:10.1093/cid/ciy757.
  • Takeuchi M, Yasunaga H, Horiguchi H, Matsuda S. The incidence of pertussis hospitalizations among Japanese infants: excess hospitalizations and complications? Epidemiol Infect. 2012;140(8):1497–1502. doi:10.1017/S0950268811002044.
  • Meulen AS, Bergquist S, Klugman KP. Global perspectives on maternal immunisation. Lancet Infect Dis. 2017;17(7):685–686. doi:10.1016/S1473-3099(17)30230-X.
  • Homaira N, He WQ, McRae J, Macartney K, Liu B. Coverage and predictors of influenza and pertussis vaccination during pregnancy: a whole of population-based study. Vaccine. 2023;41(43):6522–6529. doi:10.1016/j.vaccine.2023.09.008.
  • Juretzko P, Fabian-Marx T, Haastert B, Giani G, von Kries R, Wirsing von König CH. Pertussis in Germany: regional differences in management and vaccination status of hospitalized cases. Epidemiol Infect. 2001;127(1):63–71. doi:10.1017/S0950268801005593.
  • Fernandes EG, Sartori AMC, de Soárez PC, Amaku M, de Azevedo Neto RS, Novaes HMD. Cost-effectiveness analysis of universal adult immunization with tetanus-diphtheria-acellular pertussis vaccine (Tdap) versus current practice in Brazil. Vaccine. 2020;38(1):46–53. doi:10.1016/j.vaccine.2019.09.100.
  • Tormans G, Van Doorslaer E, van Damme P, Clara R, Schmitt HJ. Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany. Eur J Pediatr. 1998;157(5):395–401. doi:10.1007/s004310050837.
  • Mançaneira JF, Benedetti JR, Zhang L. Hospitalizations and deaths due to pertussis in children from 1996 to 2013. J Pediatr (Rio J). 2016;92(1):40–45. doi:10.1016/j.jped.2015.03.006.
  • Masseria C, Martin CK, Krishnarajah G, Becker LK, Buikema A, Tan TQ. Incidence and burden of pertussis among infants less than 1 year of age. Pediatr Infect Dis J. 2017;36(3):54–61. doi:10.1097/INF.0000000000001440.
  • Oliveira SM, Gonçalves-Pinho M, Freitas A, Guimarães H, Azevedo I. Trends and costs of pertussis hospitalizations in Portugal, 2000 to 2015: from 0 to 95 years old. Infect Dis (Lond). 2018;50(8):625–633. doi:10.1080/23744235.2018.1457796.
  • Plans-Rubió P, Navas E, Godoy P, Carmona G, Domínguez A, Jané M, Muñoz-Almagro C, Brotons P. Reduction of direct health costs associated with pertussis vaccination with acellular vaccines in children aged 0–9 years with pertussis in Catalonia (Spain). Pharmacoecon Open. 2019;3(1):55–69. doi:10.1007/s41669-018-0081-4.
  • Pham NTH, Le NDT, Le NK, Nguyen KD, Larsson M, Olson L, Tran DM. Pertussis epidemiology and effect of vaccination among diagnosed children at Vietnam, 2015-2018. Acta Paediatr. 2020;109(12):2685–91. doi:10.1111/apa.15259.
  • Stein-Zamir C, Shoob H, Abramson N, Brown EH, Zimmermann Y. Pertussis outbreak mainly in unvaccinated young children in ultra-orthodox Jewish groups, Jerusalem, Israel 2023. Epidemiol Infect. 2023;151:e166. doi:10.1017/S0950268823001577.